Cardio Diagnostic…
USUSDCardio Diagnostics Holdings Inc (US:CDIO) — Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numero di borse in cui sono quotate le azioni della società: 1. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'azienda
- Sito web
- cardiodiagnosticsinc.com
- Settore
- Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sede centrale
- CHICAGO, United States
- Amministratore delegato
- Meeshanthini V. Dogan
- Dipendenti
- 15
- Azioni in circolazione
- 2.96 Mln al 2026-08-07
- Flottante
- 2.84 Mln
- Capitalizzazione di mercato
- 5.8 Mln USD
- Insider
- 8.31%
- Investitori istituzionali
- 6.52%
- Settore (SIC)
- In Vitro & In Vivo Diagnostic Substances
- FCF
- −5.82 Mln USD
- Debito
- 967 k USD
- Utili e FCF — per i 12 mesi a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Borse e ticker
| Borsa | Ticker | Valuta | Prezzo | Tipo |
|---|---|---|---|---|
| US USA Stocks | CDIO | USD | 1.86 -5.10% | azioni ordinarie |
Notizie di questa settimana
Ancora nessuna notizia dal sito della società.
Principali azionisti
| Detentore | Quota | Azioni | Data del rapporto |
|---|---|---|---|
| Renaissance Technologies… | 1.66% | 49 200 | 2026-06-30 |
| Blackrock Inc. | 1.17% | 34 708 | 2026-06-30 |
| Geode Capital Management… | 0.89% | 26 233 | 2026-06-30 |
| Vanguard Capital Managem… | 0.68% | 20 155 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.68% | 20 155 | 2026-06-30 |
| Citadel Advisors Llc | 0.64% | 19 071 | 2026-06-30 |
| Xtx Topco Ltd | 0.54% | 16 093 | 2026-06-30 |
| Fidelity Concord Street… | 0.53% | 15 743 | 2026-07-31 |
| Jane Street Group, LLC | 0.4% | 11 933 | 2026-06-30 |
| State Street Corporation | 0.34% | 10 099 | 2026-06-30 |
| Fidelity Concord Street… | 0.1% | 2 826 | 2026-07-31 |
| Vanguard Fiduciary Trust… | 0.1% | 2 824 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 2 251 | 2026-07-31 |
| Tower Research Capital L… | 0.06% | 1 809 | 2026-06-30 |
